Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018729
Filing Date
2016-05-10
Accepted
2016-05-09 21:43:47
Documents
71
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srne-10q_20160331.htm 10-Q 1080430
2 EX-10.1 srne-ex101_537.htm EX-10.1 89069
3 EX-31.1 srne-ex311_7.htm EX-31.1 9647
4 EX-31.2 srne-ex312_11.htm EX-31.2 9593
5 EX-32.1 srne-ex321_6.htm EX-32.1 10944
  Complete submission text file 0001564590-16-018729.txt   6303827

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srne-20160331.xml EX-101.INS 1268166
7 XBRL TAXONOMY EXTENSION SCHEMA srne-20160331.xsd EX-101.SCH 63698
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20160331_cal.xml EX-101.CAL 53032
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20160331_def.xml EX-101.DEF 236973
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20160331_lab.xml EX-101.LAB 478332
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20160331_pre.xml EX-101.PRE 384928
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 161633455
SIC: 8731 Services-Commercial Physical & Biological Research